Skip to main content
Clinical Trials/ISRCTN89178223
ISRCTN89178223
Recruiting
未知

Pre-emptive rehabilitation to prevent dialysis associated morbidity (PREHAB-2): a study to assess the impact of exercise, nutritional intervention and multidisciplinary education upon outcomes in patients approaching and commencing dialysis

Derby Teaching Hospitals NHS Foundation Trust0 sites60 target enrollmentMarch 20, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Renal failure
Sponsor
Derby Teaching Hospitals NHS Foundation Trust
Enrollment
60
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 20, 2018
End Date
June 30, 2020
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Male and female aged 18 years and above
  • 2\. eGFR less than 15mls/min
  • 3\. Rate of change in eGFR indicates that dialysis will be initiated within 12 months from commencing the study
  • 4\. Attending the low clearance clinic
  • 5\. Patient has opted for dialysis
  • 6\. Patient is able to exercise

Exclusion Criteria

  • 1\. Patient is not predicted to require dialysis within 12 months of commencing the study
  • 2\. Patient has chosen conservative care rather than opting for dialysis
  • 3\. Severe physical impairment and/or significant comorbidity that makes exercise impossible or unsafe, defined by exercise\-induced angina, inability to walk less than 50 metres, or dyspnoea with effort
  • 4\. Insufficient command of English to provide informed consent or comply with the testing protocol and exercise and education component (if results indicate the intervention to be beneficial, future studies will include provision for such patients)
  • 5\. Patient is pregnant (therefore is unable to undergo Dual X\-Ray Absorption (DEXA) Scan)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Reduction of the risk of dialysisN04N17.9N18.1N18.2N18.3N18.4N18.5N19R31R80Nephrotic syndromeAcute renal failure, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 2Chronic kidney disease, stage 3Chronic kidney disease, stage 4Chronic kidney disease, stage 5Unspecified kidney failureUnspecified haematuriaIsolated proteinuria
DRKS00029691KfH-Stiftung Präventivmedizin,357
Active, not recruiting
Phase 1
Early prospective therapy trial to delay renal failure in children with Alport syndrome. - EARLY PRO-TECT AlportAlport's syndromeMedDRA version: 19.1Level: PTClassification code 10001843Term: Alport's syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2010-024300-10-DEniversity Medical Center Göttingen66
Unknown
Not Applicable
Prevention of dialysate-induced peritoneal damage by pyridoxal phosphatePatients with end-stage renal disease on peritoneal dialysis
JPRN-UMIN000001287Miyanomori Memorial Hospital40
Completed
Not Applicable
utritional intervention for hemodialysis patients with locomotive syndromelocomotive syndrome hemodialysis
JPRN-UMIN000032457Shinkohkai Murakamikinen Hospital Department of Nutrition40
Not yet recruiting
Phase 3
Desensitization of highly pre-sensitized dialysis patients waiting for kidney transplantation by Rituximab, IVIG-L and rescue Plasmapheresis THE DRIP STUDYniertransplantatieTransplantation
NL-OMON30466Academisch Medisch Centrum12